AWArthur W. Coviello

1. Article · Aug 10, 2026 · Arthur W. Coviello

   Federal Circuit Patent Watch: Patent Not Enabled Where Specification "Disclosed No Actual Dosages For Any Compound Within The Scope Of The Claims" (opens the original)

   Excerpt · English

   Read excerpt

   1. INTELLECTUAL PIXELS LIMITED v. SONY INTERACTIVE ENTERTAINMENT LLC [OPINION] (2024‑2174, 07/10/2026) (Dyk, Stoll, Stark) Dyk, J. The Court affirmed the Patent Trial and Appeal Board’s decision on remand holding claims 1–12 of U.S. Patent No. 10,681,109 unpatentable as obvious. The patent relates to methods for generating digital images using an external visual server and systems implementing the disclosed method. In an earlier appeal, the Court vacated the Board’s initial decision finding the

   Feedback

2. Article · Jul 7, 2026 · Arthur W. Coviello

   Federal Circuit Patent Watch: Federal Circuit Clarifies The Skilled Searcher Standard For IPR Estoppel And Holds That District Court Relied On Insufficient Evidence To Apply IPR Estoppel (opens the original)

   Excerpt · Neutral tone · English

   Read excerpt

   1. ENANTA PHARMACEUTICALS, INC v. PFIZER INC. (2025-1427, 6/23/2026) (Lourie, Bryson, Chen) Lourie, J. The Court affirmed the district court’s grant of summary judgment that the claims of the asserted patent are invalid as anticipated by a public disclosure of a compound within the scope of the claims. The issue in this appeal was whether the disclosure of —NHC(O)—C2-C12-alkyl in a provisional application from which the asserted patent claimed priority provided adequate written description suppo

   Feedback

Last 90 days. Choose a month to open its work.

Named in the text we hold. One piece can cover several.

• Appeal Board1 piece
• Federal Rule1 piece
• Civil Procedure1 piece
• Cold Chain1 piece
• Boston Scientific1 piece
• Federal Circuit1 piece
• Third Circuit1 piece